Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APLMW NASDAQ:DRTSW NASDAQ:SXTPW NASDAQ:TRAX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPLMWApollomics$0.02-8.4%$0.01$0.00▼$0.05N/AN/A19,014 shs32,930 shsDRTSWAlpha Tau Medical$2.00+10.8%$1.04$0.20▼$2.26N/AN/A52,004 shs138,373 shsSXTPW60 Degrees Pharmaceuticals$0.05-0.2%$0.06$0.03▼$0.16N/AN/A14,657 shs3,275 shsTRAXFirst Tracks Biotherapeutics$18.16-1.5%$0.00$14.79▼$26.80$633.64MN/A415,347 shs211,577 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPLMWApollomics-8.38%-12.57%+3.38%+2.68%+37.84%DRTSWAlpha Tau Medical+10.83%+97.72%+112.23%+75.00%+778.85%SXTPW60 Degrees Pharmaceuticals-0.19%+12.39%-42.56%-17.81%-13.26%TRAXFirst Tracks Biotherapeutics-1.47%+1.91%+1,815,999,900.00%+1,815,999,900.00%+1,815,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPLMWApollomics$0.02-8.4%$0.01$0.00▼$0.05N/AN/A19,014 shs32,930 shsDRTSWAlpha Tau Medical$2.00+10.8%$1.04$0.20▼$2.26N/AN/A52,004 shs138,373 shsSXTPW60 Degrees Pharmaceuticals$0.05-0.2%$0.06$0.03▼$0.16N/AN/A14,657 shs3,275 shsTRAXFirst Tracks Biotherapeutics$18.16-1.5%$0.00$14.79▼$26.80$633.64MN/A415,347 shs211,577 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPLMWApollomics-8.38%-12.57%+3.38%+2.68%+37.84%DRTSWAlpha Tau Medical+10.83%+97.72%+112.23%+75.00%+778.85%SXTPW60 Degrees Pharmaceuticals-0.19%+12.39%-42.56%-17.81%-13.26%TRAXFirst Tracks Biotherapeutics-1.47%+1.91%+1,815,999,900.00%+1,815,999,900.00%+1,815,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPLMWApollomics 0.00N/AN/AN/ADRTSWAlpha Tau Medical 0.00N/AN/AN/ASXTPW60 Degrees Pharmaceuticals 0.00N/AN/AN/ATRAXFirst Tracks Biotherapeutics 3.00Buy$39.43117.12% UpsideCurrent Analyst Ratings BreakdownLatest TRAX, SXTPW, DRTSW, and APLMW Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/4/2026TRAXFirst Tracks Biotherapeutics Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$54.004/28/2026TRAXFirst Tracks Biotherapeutics HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$30.004/28/2026TRAXFirst Tracks Biotherapeutics HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy$30.004/27/2026TRAXFirst Tracks Biotherapeutics Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold4/24/2026TRAXFirst Tracks Biotherapeutics WedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$30.004/24/2026TRAXFirst Tracks Biotherapeutics Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$46.004/23/2026TRAXFirst Tracks Biotherapeutics JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$31.004/22/2026TRAXFirst Tracks Biotherapeutics BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$40.004/21/2026TRAXFirst Tracks Biotherapeutics UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$45.00(Data available from 5/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPLMWApollomics$8.50MN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/AN/ASXTPW60 Degrees Pharmaceuticals$1.01MN/AN/AN/AN/AN/ATRAXFirst Tracks BiotherapeuticsN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPLMWApollomicsN/AN/AN/AN/AN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/AN/AN/AN/A5/25/2026 (Estimated)SXTPW60 Degrees PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AN/ATRAXFirst Tracks BiotherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AN/ALatest TRAX, SXTPW, DRTSW, and APLMW EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/25/2026N/ADRTSWAlpha Tau Medical-$0.1236N/AN/AN/A$0.05 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAPLMWApollomicsN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/ASXTPW60 Degrees PharmaceuticalsN/AN/AN/AN/AN/ATRAXFirst Tracks BiotherapeuticsN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPLMWApollomicsN/ADRTSWAlpha Tau MedicalN/ASXTPW60 Degrees PharmaceuticalsN/ATRAXFirst Tracks BiotherapeuticsN/AInsider OwnershipCompanyInsider OwnershipAPLMWApollomicsN/ADRTSWAlpha Tau MedicalN/ASXTPW60 Degrees PharmaceuticalsN/ATRAXFirst Tracks BiotherapeuticsN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPLMWApollomics59N/AN/ANot OptionableDRTSWAlpha Tau Medical80N/AN/ANot OptionableSXTPW60 Degrees Pharmaceuticals2N/AN/ANot OptionableTRAXFirst Tracks BiotherapeuticsN/A34.89 millionN/AN/ATRAX, SXTPW, DRTSW, and APLMW HeadlinesRecent News About These CompaniesFirst Tracks Biotherapeutics Inc.May 14 at 8:45 PM | wsj.comFirst Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued : TRAXVMay 14 at 8:45 PM | 247wallst.comFirst Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business UpdateMay 14 at 4:15 PM | globenewswire.comFirst Tracks Biotherapeutics Inc TRAXMay 13 at 12:55 PM | morningstar.comMFirst Tracks Biotherapeutics Stock Slides After Investors Move to Sell 10 Million SharesMay 8, 2026 | marketwatch.comFirst Tracks: Huge Cash Reserves Will Not Sustain Testing For LongMay 6, 2026 | seekingalpha.comFirst Tracks Biotherapeutics (NASDAQ:TRAX) Receives $38.40 Consensus PT from AnalystsMay 5, 2026 | americanbankingnews.comAnalysts Are Bullish on Top Healthcare Stocks: Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD), First Tracks Biotherapeutics Inc (TRAX)May 3, 2026 | theglobeandmail.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTRAX, SXTPW, DRTSW, and APLMW Company DescriptionsApollomics NASDAQ:APLMW$0.02 0.00 (-8.38%) As of 05/14/2026 02:41 PM EasternApollomics, Inc., a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways. Its solutions include tumor inhibitors, anti-cancer enhancers, and immune-oncology drugs. Apollomics, Inc. was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc. was incorporated in 2016 and is based in Foster City, California with additional locations in Hangzhou and Shanghai, China and Southbank, Australia.Alpha Tau Medical NASDAQ:DRTSW$2.00 +0.20 (+10.83%) Closing price 05/14/2026 03:59 PM EasternExtended Trading$2.00 +0.00 (+0.25%) As of 05/14/2026 04:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.60 Degrees Pharmaceuticals NASDAQ:SXTPW$0.05 0.00 (-0.19%) As of 05/14/2026 10:46 AM Eastern60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.First Tracks Biotherapeutics NASDAQ:TRAX$18.16 -0.27 (-1.47%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$17.52 -0.64 (-3.50%) As of 04:36 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas YETI Rallies After Earnings Beat and Raised Outlook Cisco’s Vertical Rally May Still Be in the Early Innings Dividend Growth or High Yield: The Income Investor's Bet Nebius Upside Expands as AI Feedback Loop Intensifies Oklo Stock Could Be Ready for Another Massive Run Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell Qualcomm Stock Doubles: New Era? Or Another False Start? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
